Category: Latest News
-
Argan Shares Rise After Q2 Earnings and Revenue Exceed Estimates
Argan (NYSE:AGX) shares rose 9.4% in premarket trading after the engineering and construction company reported fiscal second-quarter earnings and revenue above analyst expectations. For the quarter ended July 31, 2026, Argan reported adjusted earnings per share of $3.76, compared with the Wall Street consensus estimate of $2.66. Quarterly revenue reached a record $384 million, an…
-
Petco Shares Rise After Q2 Earnings Exceed Estimates
Petco Health and Wellness Company Inc (NASDAQ:WOOF) shares rose 11.8% in premarket trading after the pet specialty retailer reported fiscal second-quarter 2026 earnings above analyst expectations and adjusted EBITDA above its previous guidance range. Petco reported earnings per share of $0.113, compared with the analyst consensus estimate of $0.071. Revenue was $1.49 billion, in line…
-
Netskope Shares Rise After Q2 Revenue Exceeds Estimates
Netskope (NASDAQ:NTSK) shares rose 11.3% to $15.30 in premarket trading after the cloud and AI security company reported fiscal second-quarter 2027 revenue and adjusted earnings above analyst expectations. Revenue for the quarter ended July 31, 2026 increased 29% year over year to $221 million, compared with the Wall Street consensus estimate of $214.2 million. Netskope…
-
ChargePoint Shares Rise After Q2 Revenue Exceeds Estimates
ChargePoint (NYSE:CHPT) shares rose 18.3% in premarket trading after the electric vehicle charging network operator reported fiscal second-quarter 2027 revenue and adjusted earnings above analyst expectations. Revenue for the quarter ended July 31, 2026 was $116 million, an increase of 18% from the prior-year period and above the analyst consensus estimate of approximately $105 million.…
-
bioAffinity Technologies Shares Rise After CyPath Lung Surveillance Update
bioAffinity Technologies (NASDAQ:BIAF) shares rose 39.4% in premarket trading after the company announced that its CyPath® Lung noninvasive diagnostic test is now positioned for post-curative surveillance of lung cancer recurrence. The company said the test can be used by physicians to monitor lung cancer survivors for recurrence and alongside routine imaging when new pulmonary nodules…
-
Apple Faces £2 Billion UK Lawsuit Over App Tracking Transparency Rules
Apple (NASDAQ:AAPL) is facing a £2 billion ($2.7 billion) lawsuit in London brought on behalf of app developers over its App Tracking Transparency rules, with the claim alleging that the company imposed stricter requirements on third-party developers than on its own services. The lawsuit was filed at London’s Competition Appeal Tribunal on Thursday and follows…
-
Ultragenyx Shares Fall After Phase 3 Aspire Study Misses Primary Endpoint
Ultragenyx (NASDAQ:RARE) shares fell 44.7% to $14.67 in premarket trading after the company disclosed that its pivotal Phase 3 Aspire study evaluating apazunersen (GTX-102) in Angelman syndrome did not meet its primary or key secondary endpoints. The company announced the results late Wednesday. The study’s primary endpoint measured the change from baseline in the Bayley-4…
-
Falco Resources Advances Horne 5 as Feasibility Study Highlights Significant Economic Potential
Falco Resources (TSXV:FPC) (USOTC:FPRGF) is entering an important phase in the development of its flagship Horne 5 project, with an updated feasibility study providing investors with a clearer picture of the project’s scale, economics and potential path toward development. Located in Quebec, Canada, Horne 5 is a large-scale polymetallic project positioned within an established mining…
-
Peraso Inc. Targets Growing Defence Opportunity with Secure 60 GHz Millimeter Wave Technology
Modern defence systems increasingly depend on the ability to move large volumes of data quickly, securely and reliably. As military platforms become more connected and autonomous, the demand for resilient communications links is creating new opportunities for technologies designed to operate in challenging and contested environments. For Peraso Inc. (NASDAQ:PRSO), this represents an important potential…
-
Broadcom Shares Slip as Q4 Revenue Forecast Falls Below Estimates
Broadcom (NASDAQ:AVGO) shares fell nearly 2% in premarket trading on Thursday after the company forecast fourth-quarter revenue below Wall Street estimates, while CEO Hock Tan outlined revenue projections for fiscal 2027 and 2028 during the company’s earnings call. Broadcom expects fourth-quarter revenue of approximately $34.8 billion, compared with analysts’ average estimate of $35.05 billion. The…